GAPDH over-expression may be attributed to compensate for the progressive decrease in muscle mitochondrial function due to FFA induced ROS and contribute to loss of glucose and lipid homeostasis and eventually obesity and T2D [112], [113]. Here, GAPDH is linked to obesity disorder.